Achilles Therapeutics PLC (ACHL)
1.04
+0.02
(+1.46%)
USD |
NASDAQ |
Nov 05, 14:52
Achilles Therapeutics Market Cap: 42.73M for Nov. 5, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 04, 2024 | 42.12M |
| November 01, 2024 | 41.91M |
| October 31, 2024 | 41.09M |
| October 30, 2024 | 41.91M |
| October 29, 2024 | 40.89M |
| October 28, 2024 | 40.68M |
| October 25, 2024 | 40.27M |
| October 24, 2024 | 40.27M |
| October 23, 2024 | 41.08M |
| October 22, 2024 | 40.88M |
| October 21, 2024 | 40.76M |
| October 18, 2024 | 41.09M |
| October 17, 2024 | 40.68M |
| October 16, 2024 | 40.68M |
| October 15, 2024 | 40.47M |
| October 14, 2024 | 40.47M |
| October 11, 2024 | 40.62M |
| October 10, 2024 | 40.14M |
| October 09, 2024 | 41.09M |
| October 08, 2024 | 41.91M |
| October 07, 2024 | 41.50M |
| October 04, 2024 | 42.16M |
| October 03, 2024 | 41.91M |
| October 02, 2024 | 40.69M |
| October 01, 2024 | 41.09M |
| Date | Value |
|---|---|
| September 30, 2024 | 41.91M |
| September 27, 2024 | 41.70M |
| September 26, 2024 | 40.35M |
| September 25, 2024 | 39.24M |
| September 24, 2024 | 39.03M |
| September 23, 2024 | 40.09M |
| September 20, 2024 | 42.73M |
| September 19, 2024 | 38.62M |
| September 18, 2024 | 29.17M |
| September 17, 2024 | 29.09M |
| September 16, 2024 | 29.01M |
| September 13, 2024 | 29.70M |
| September 12, 2024 | 29.17M |
| September 11, 2024 | 28.77M |
| September 10, 2024 | 29.38M |
| September 09, 2024 | 29.58M |
| September 06, 2024 | 29.58M |
| September 05, 2024 | 29.21M |
| September 04, 2024 | 28.97M |
| September 03, 2024 | 29.14M |
| August 30, 2024 | 29.58M |
| August 29, 2024 | 30.26M |
| August 28, 2024 | 29.46M |
| August 27, 2024 | 30.91M |
| August 26, 2024 | 30.91M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
28.77M
Minimum
Sep 11 2024
725.51M
Maximum
Apr 06 2021
124.78M
Average
50.76M
Median
Jan 31 2023
Market Cap Benchmarks
| Autolus Therapeutics PLC | 890.09M |
| Biodexa Pharmaceuticals PLC | 3.369M |
| Centessa Pharmaceuticals PLC | 2.047B |
| Adaptimmune Therapeutics PLC | 210.38M |
| Verona Pharma PLC | 3.117B |
Market Cap Related Metrics
| Price to Book Value | 0.3700 |
| Price | 1.04 |
| Earnings Yield | -152.9% |